Fracture risk assessment in diabetes mellitus
Authors:
Open Access
- 2 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 961761
Abstract
Growing evidence suggests that diabetes mellitus is associated with an increased risk of fracture. Bone intrinsic factors (such as accumulation of glycation end products, low bone turnover, and bone microstructural changes) and extrinsic factors (such as hypoglycemia caused by treatment, diabetes peripheral neuropathy, muscle weakness, visual impairment, and some hypoglycemic agents affecting bone metabolism) probably contribute to damage of bone strength and the increased risk of fragility fracture. Traditionally, bone mineral density (BMD) measured by dual x-ray absorptiometry (DXA) is considered to be the gold standard for assessing osteoporosis. However, it cannot fully capture the changes in bone strength and often underestimates the risk of fracture in diabetes. The fracture risk assessment tool is easy to operate, giving it a certain edge in assessing fracture risk in diabetes. However, some parameters need to be regulated or replaced to improve the sensitivity of the tool. Trabecular bone score, a noninvasive tool, indirectly evaluates bone microstructure by analyzing the texture sparsity of trabecular bone, which is based on the pixel gray level of DXA. Trabecular bone score combined with BMD can effectively improve the prediction ability of fracture risk. Quantitative computed tomography is another noninvasive examination of bone microstructure. High-resolution peripheral quantitative computed tomography can measure volume bone mineral density. Quantitative computed tomography combined with microstructure finite element analysis can evaluate the mechanical properties of bones. Considering the invasive nature, the use of microindentation and histomorphometry is limited in clinical settings. Some studies found that the changes in bone turnover markers in diabetes might be associated with fracture risk, but further studies are needed to confirm this. This review focused on summarizing the current development of these assessment tools in diabetes so as to provide references for clinical practice. Moreover, these tools can reduce the occurrence of fragility fractures in diabetes through early detection and intervention.Keywords
This publication has 109 references indexed in Scilit:
- Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal WomenInternational Journal of Endocrinology, 2013
- Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studiesEuropean Journal of Epidemiology, 2012
- Trabecular bone histomorphometry in humans with Type 1 Diabetes MellitusBone, 2012
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 DiabetesJAMA, 2011
- Microindentation for in vivo measurement of bone tissue mechanical properties in humansJournal of Bone and Mineral Research, 2010
- Pentosidine and Increased Fracture Risk in Older Adults with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2009
- High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesisBone, 2008
- Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and ActionJournal of Biological Chemistry, 2007
- Regulation of osteoclast function and bone mass by RAGEJournal of Experimental Medicine, 2006
- Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) StudyOsteoporosis International, 2004